JPRN-UMIN000017523Recruiting未知
Prospective and Non-interventional registry to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation at Fukui Red Cross Hospital - Prospective and Non-interventional registry to Investigate pharmacokinetics (for the coagulation/fibrinolysis status and vascular function) and Safety of Rivaroxaban in Patients with Non-valvular Atrial Fibrillation (FENIX Registry)
Fukui Red Cross Hospital0 sites100 target enrollmentStarted: May 12, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The following patients in whom rivaroxaban is contraindicated for use - Patients with a history of allergies to the ingredients contained in this drug - Patients having a hemorrhagic event (intracranial hemorrhage, gastrointestinal hemorrhage or other clinically significant hemorrhagic events) - Patients having liver disease complicated with coagulation disorder or those having moderate or worse liver disorder (Grade B or C in accordance with the Child-Pugh classification) - Patients having renal failure (creatinine clearance <15 mL/min) - Women who are or are likely to be pregnant - Patients who are treated with HIV protease inhibitors (including ritonavir, atazanavir and indinavir) - Patients who are treated with oral or injectable formulations of azole antifungal drugs (including itraconazole, voriconazole and ketoconazole (excluding fluconazole)) -Patients with acute bacterial endocarditis - Patients have remaining effects are received with other anticoagulation therapy -Patients are unstable state of blood pressure(18/120mmHg>)
Investigators
Similar Trials
Completed
Not Applicable
A pan-india non-interventional virtual registry evaluating the prophylactic efficacy of different regimens against SARS-CoV2 infection (COVID-2019) in asymptomatic health care workersCTRI/2020/04/024482Zifo RnD Solutions391
Recruiting
Not Applicable
on-interventional, Prospective register concerning treatment of cervical cancer FIGO IB - IIA by nerve-sparing total mesometrial resection and therapeutic lymphadenectomy (TMMR/tLNE) according to M. Hoeckel.C53Malignant neoplasm of cervix uteriDRKS00004793niversitätsklinikum Essen300
Recruiting
Not Applicable
A multi-center and non-interventional registry of Brentuximab Vedotin in patients with relapsed or refractory anaplastic large cell lymphoma or classical Hodgkin lymphomaKCT0003789Samsung Medical Center150
Recruiting
Not Applicable
A multi center and non interventional registry of Korean Medicine Treatment for Patients with Shoulder pain.KCT0007128Kyung Hee University Oriental Medicine Hospital at Gangdong400
Recruiting
Not Applicable
Prospective non-interventional registry study entitled:Peripartum outcome in vaginally targeted final pelvic births and influencing factorsO32.1Maternal care for breech presentationDRKS00025030Zentrum für Frauenheilkunde und Geburtshilfe Universitätsklinikum Frankfurt am Main1,500